Prevent Blindness declares January National Glaucoma Awareness Month

Article

Prevent Blindness and other eye health organizations have declared January as National Glaucoma Awareness Month. Prevent Blindness seeks to educate the public on the second leading cause of blindness, following cataracts, by providing free resources via online or by mail through its Glaucoma Learning Center.

Chicago-Prevent Blindness and other eye health organizations have declared January as National Glaucoma Awareness Month. Prevent Blindness seeks to educate the public on the second leading cause of blindness, following cataracts, by providing free resources via online or by mail through its Glaucoma Learning Center.

Glaucoma risk factors include:

• Age. Those who are 40 and older are more likely to develop glaucoma. The older you are, the greater your risk.

• Race. People of African or Afro-Caribbean heritage are more likely to develop glaucoma than the rest of the population. They are also more likely to develop glaucoma at a younger age.  

• Family history. If you have a parent or sibling who has glaucoma, you are more likely to develop the disease.

• Diabetes. People with diabetes have a higher risk (40 percent) of developing glaucoma.

• Myopia. People who are very myopic are at greater risk.

• Eye injury or surgery. Those who have had eye surgery or eye injuries may develop secondary glaucoma.

• Steroid medication. Steroids may increase the risk of glaucoma when used for extended periods of time. 

Prevent Blindness has recently put together free fact sheets for your patients to help answer common questions about health insurance, Medicare coverage for glaucoma, the Affordable Care Act, and eye care.

According to the 2013 Cost of Vision Problems: The Economic Burden of Vision Loss and Eye Disorders in the United States report, glaucoma and disorders of the optic nerve annually cost $5.8 billion, with an annual per-person treatment cost of $2,170. 

Recent Videos
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
© 2025 MJH Life Sciences

All rights reserved.